MedPath

Nostrum Laboratories, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.nostrumlabs.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

FDA:18

Drug Approvals

PROMETHAZINE HYDROCHLORIDE

Approval Date
Feb 17, 2024
FDA

Carbamazepine

Approval Date
Feb 15, 2024
FDA

PROMETHAZINE HYDROCHLORIDE

Approval Date
Jan 18, 2024
FDA

Theophylline

Approval Date
Aug 15, 2023
FDA

Dapsone

Approval Date
Jan 20, 2023
FDA

Acetazolamide

Approval Date
Jun 1, 2022
FDA

Carisoprodol

Approval Date
Nov 1, 2021
FDA

Theophylline

Approval Date
Nov 1, 2021
FDA

Butalbital, Aspirin, and Caffeine

Approval Date
Oct 29, 2021
FDA

NITROFURANTOIN

Approval Date
Jun 5, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.